<DOC>
	<DOCNO>NCT01025414</DOCNO>
	<brief_summary>The primary objective study evaluate effectives enteral nutrition treatment pancreatic fistula . The ratio pancreatic fistula closure 30 day select primary outcome measure null hypothesis assume enteral nutrition provide good result parenteral nutrition far closure ratio , time closure treatment-related complication concern .</brief_summary>
	<brief_title>Enteral Nutrition Treatment Pancreatic Fistulas - A Prospective Study</brief_title>
	<detailed_description>The research field role enteral nutrition treatment pancreatic fistula fully justify low cost complication ' rate EN compare PN observe clinical trial compare enteral parnetral route feed pre- postoperative period . Such author Braga , Torosian , Lewis Sand et al . prove use enteral nutrition lead small amount complication ( especially infectious ) improve outcome surgery . The method verify role enteral nutrition prospective , randomized clinical trial . STUDY OBJECTIVES 2.1 Primary Objective The primary objective study evaluate effectives enteral nutrition treatment pancreatic fistula . The ratio pancreatic fistula closure 30 day select primary outcome measure null hypothesis assume enteral nutrition provide good result parenteral nutrition far closure ratio , time closure treatment-related complication concern . 2.2 Secondary Objectives The secondary objective : - determine time fistula closure ( defined time initiation treatment confirm fistula closure ) , - determine rate fistula treatment-related complication , - ass change quality life ( QoL ) , - determine economic cost therapy . ( term : fistula closure , time closure see definition page 3 ) For QoL assessment EORTC QLQ - PAN26 score Polish version ( translation approve EORTC ) use . Benefits study : 1. implementation safer less expensive conservative procedure . Basis : Costs enteral nutrition significantly low PN EN significantly safer PN especially far infectious complication concern . 2. enhancement indication enteral nutrition . The confirmation null hypothesis allow recommend enteral nutrition method choice pancreatic fistula treatment .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Pancreatic Fistula</mesh_term>
	<criteria>presence pancreatic fistula ( PF ) ( verification serum lipase concentration drain fluid , finding image modality : endoscopic retrograde cholangiopancreatography ( ERCP ) , helical compute tomography ( hCT ) , magnetic reissonance imaging ( MRI ) , ultrasonography ( USG ) intraoperative surgeon 's verification ) good general status ( Karnoffsky &gt; 80 , Eastern Cooperative Oncology Group ( ECOG ) scale 0 1 ; see Appendix 2 ) ; NRS MUST evaluation low/ medium risk patient require parenteral nutrition essence treatment option , PF 's complication require special treatment present , intraabdominal abscess formation , pleuropneumonia , bleeding , paralytic ileus , etc . Complications diagnose treated accord generally accept medical knowledge , standard procedure . age 80 18 ; case neoplastic patient : confirm neoplastic dissemination distant metastasis ; severe concomitant disease ( heart failure , COPD , CABG , etc . ) ; history know allergy drug intolerance ; inform consent PF diagnosis uncertain ; poor general status ( Karnoffsky &lt; 80 , ECOG &gt; 1 ) ; presence serious complication ; see recent history severe heart , lung , kidney liver failure ; history allergy drug intolerance ; confirm neoplastic spread ; severe malnutrition require combine treatment ( PN+EN ) withdrawal consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>pancreatic fistula</keyword>
</DOC>